-3%
Pro Fertilmax is indicated for the management of male infertility, particularly in conditions such as:
Oligospermia – reduced sperm concentration in semen
Asthenozoospermia – decreased sperm motility affecting fertilization potential
Teratozoospermia – abnormal sperm morphology associated with impaired fertility
Pharmacology & Clinical Benefits
Significantly improves key semen parameters, including:
- Sperm count
- Sperm motility
- Sperm morphology
- Semen volume
The unique patented combination demonstrates a synergistic effect, showing superior outcomes compared to high-dose single-ingredient therapies.
Reduces sperm DNA fragmentation and enhances DNA integrity, which may lower the risk of miscarriage and improve reproductive outcomes.
Clinically proven fertility outcomes:
Pregnancy rate 41.3% in PROFERTIL subgroup (DFI >15%) vs 22.9% in control group
Overall pregnancy rate 27.8% with PROFERTIL vs 15.3% in control population
Supports recovery of sperm quality following COVID-19 infection.
